Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Bitget launches "Double 11 VIP Exclusive Event"

Bitget launches "Double 11 VIP Exclusive Event"

ForesightNewsForesightNews2025/11/10 04:52
Show original

Foresight News reports that Bitget has launched the "Double 11 VIP Exclusive Event," open to all users in Chinese-speaking regions. During the event, VIP users from other platforms only need to fill out a form to enjoy Bitget VIP 6 preferential rates for 15 days, with Maker fees as low as 0.008% and Taker fees at 0.03%. Regular users, users from other platforms, or existing VIPs who register and upgrade their VIP level by +1 through contract trading volume will receive a 350 or 700 USDT trial fund reward. The event period is from November 10, 11:00 (UTC+8) to November 16, 23:59 (UTC+8).


In addition, from November 11, 00:00 (UTC+8) to November 12, 23:59 (UTC+8), all official VIPs will have access to flash sale privileges. After registering and reaching a contract trading volume of 1000 USDT, users can have a 100% chance to draw a 10 - 1111 USDT contract trial fund. Detailed rules have been published on the official Bitget platform. Users must click the "Join Now" button to complete registration and participate in the event.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks